International Congress on Oncology Research and Development (iCORD)

By August 29, 2019 November 25th, 2019 No Comments

International Congress on Oncology Research and Development (iCORD), hosted by Saliegral International will be held at Taj Palace, Delhi, from October 05- 06, 2019.

iCORD is an initiative and attempt to bring practicing oncologists, Researchers, Pharmaceutical companies, Diagnostic labs, Research based start-ups exploring newer treatment modalities and patient support and advocacy groups to a common platform to discuss and advocate the latest developments in oncology research, drugs, diagnostics, technology, therapies and patient care programs in India.

iCORD is an independent platform for industry, oncologists, academia and other stakeholders to come together, deliberate, learn and promote the best of science. This will help cancer patients in India in getting the high standard of care in parallel to global healthcare standards.


  • Cancer Care in India: Dr Indu Bhushan, Dr C S Parmesh and Dr Rajiv Sarin will discuss the changing landscape of cancer in India from Policy making
  • Immunetherapy: Led by Dr Govind Babu and chaired by Dr D C Doval a panel of experts will discuss the status and recent advanvces in Immunetherapy
  • Expert panels on NSCLC, Head and Neck, Hepatocellular carcinomas
  • Expert presentations and discussion on Newer therapeutic approaches like

Stem Cell Therapy, Gene Therapy and Cell Based therapies

  • Panel discussion on practical use of Liquid Biopsy lead by Dr Anurag Mehta with an expert
  • A thought provoking panel lead by Dr G S Bhattacharya on Affordable Cancer therapy with expert panel comprising of Dr Ravi Kannan and Dr Shripad Banavali
  • An overview of Cell Based Therapy landscape in Asia by Dr Aung Myo, complexities of logistics involved in these
  • Expert panels and debates on Proton therapy, Photon therapy, Radiopharmaceuticals and role of AI in Radiology and cancer management
  • An detailed and exhaustive session on Indolent Lymphoma landscape
  • Industry lead panel discussion on interesting topics like Biosimilars and

Oncology Clinical Trial in India

  • Sessions on Patient perspectives, supportive care and role of Patient Advocacy groups


15 September 2019 – Last date to Avail Special Rates for Registration 05 – 06 October 2019 – Main Conference at Taj Palace, Delhi

5th Oct 2019 – Networking Reception and Dinner


  1. Dr Aung Myo, Tessa Therapeutics, Singapore
  2. Dr Pankaj M Shah, Zydus Hospital, Ahmadabad
  3. Govind K Babu, HCG, Bangalore
  4. Dr Chirag Desai, VIMS, Ahmadabad
  5. Dr GS Bhattacharyya, SLMC, Kolkatta
  6. Dr Chetan Deshmukh, DMH, Pune
  7. Dr Manoj Kumar Sharma, Fortis, Noida
  8. Chandragouda Dodagoudar, BLK, Delhi
  9. Dr Shailesh A Bondarde, SSSH, Nashik
  10. Dr Vamshi M Krishna, Apollo, Hyderabad
  11. Suhail Ali, Executive Director-Oncology, Syneos Health

For Information Please Contact:

Devashish Rawat at, +91-8375840540


Author admin

More posts by admin

Leave a Reply